CD4 and tuberculosis: A recent clinical trial by Abdool Karim et al., comparing the outcomes in early versus late ART concluded that in severely immune-compromised patients with CD4 counts less than 50/mm3, ART should be started as soon as possible after the start of TB treatment [38].